Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Oct;11(5):735-737.
doi: 10.21037/hbsn-22-362.

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma

Affiliations
Editorial

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma

Margaret L P Teng et al. Hepatobiliary Surg Nutr. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-22-362/coif). DQH has served as an advisory board member for Eisai. The other authors have no conflicts of interest to declare.

Comment on

References

    1. Huang DQ, Singal AG, Kono Y, et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab 2022;34:969-977.e2. 10.1016/j.cmet.2022.05.003 - DOI - PMC - PubMed
    1. Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2021;18:223-38. 10.1038/s41575-020-00381-6 - DOI - PMC - PubMed
    1. Tan DJH, Setiawan VW, Ng CH, et al. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH. Hepatology 2022. [Epub ahead of print]. doi: . 10.1002/hep.32758 - DOI - PubMed
    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49. 10.3322/caac.21660 - DOI - PubMed
    1. Geh D, Manas DM, Reeves HL. Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians. Hepatobiliary Surg Nutr 2021;10:59-75. 10.21037/hbsn.2019.08.08 - DOI - PMC - PubMed